Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Colorcon
Chubb
Boehringer Ingelheim
Cerilliant
McKinsey
Federal Trade Commission
US Department of Justice
Dow

Generated: January 24, 2018

DrugPatentWatch Database Preview

Isoproterenol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for isoproterenol hydrochloride and what is the scope of isoproterenol hydrochloride patent protection?

Isoproterenol hydrochloride
is the generic ingredient in six branded drugs marketed by 3M, Alpharma Us Pharms, Sanofi Aventis Us, Abbott, Abraxis Pharm, Baxter Hlthcare, Hospira, Intl Medication, Nexus Pharms, Lilly, Armour Pharm, DEY, Parke Davis, and Fisons, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for isoproterenol hydrochloride. Four suppliers are listed for this compound.
Pharmacology for isoproterenol hydrochloride

US Patents and Regulatory Information for isoproterenol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us ISUPREL isoproterenol hydrochloride TABLET;RECTAL, SUBLINGUAL 006328-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ISUPREL isoproterenol hydrochloride INJECTABLE;INJECTION 010515-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride SOLUTION;INHALATION 085540-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m DUO-MEDIHALER isoproterenol hydrochloride; phenylephrine bitartrate AEROSOL, METERED;INHALATION 013296-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ISUPREL isoproterenol hydrochloride AEROSOL, METERED;INHALATION 011178-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nexus Pharms ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 206961-001 Aug 2, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Armour Pharm ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride SOLUTION;INHALATION 087936-001 Nov 18, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride AEROSOL, METERED;INHALATION 085904-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083486-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083346-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Merck
Accenture
Citi
Novartis
Boehringer Ingelheim
Dow
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot